Predicting memory and confusion problems in older women with ovarian cancer
Part of Brain & nervous system, Cancer, Hormones & metabolism, Mental health, Women’s health & pregnancy clinical trials.
This study looks at older women with ovarian cancer to see if they experience memory problems or confusion (delirium) during treatment. It aims to better predict who might face these issues so that doctors can offer extra support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 70 or older.
- You have ovarian cancer that is either newly diagnosed or has returned for the first time.
- You have not yet started any cancer treatment or had any invasive procedure (like surgery or biopsy).
- You can understand and sign a consent form, or have someone legally authorized to do so for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows older women with newly diagnosed breast cancer to see who might develop thinking or memory problems over time. It may help researchers understand early brain risk and how treatment and other factors relate to cognitive decline.
This study looks at how chemotherapy given before surgery for ovarian cancer may affect thinking and memory. It helps doctors understand the cognitive side effects of treatment so they can better support patients.
This study looks at older adults with newly diagnosed epithelial ovarian cancer and checks health factors that can affect treatment, like day-to-day function and support needs. It may help doctors choose better care plans for older patients by understanding risks and needs early.
This study tests whether using a computer program to do brain exercises can help older adults recover from delirium—a state of confusion that sometimes happens after hospitalization. The goal is to see if this mental stimulation helps people think more clearly and recover faster.
This Phase 1/2 study tests whether taking NAC (a supplement medicine) can help prevent or reduce memory and thinking problems after platinum chemotherapy. It targets people with advanced ovarian, fallopian tube, or primary peritoneal cancer who are starting at least six cycles of platinum-based treatment.
This trial tests a special exercise program during chemotherapy before surgery. It may help patients with certain gynecologic cancers get stronger and better prepared for treatment.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.